logo

For the Inventor, By the Inventor

Mountain Lakes, NJ, United States of America

William J Houlihan

This inventor holds 74 USPTO granted patents, primarily in Pharmaceutical Chemistry (CPC class 2605). Top assignees: Sandoz Gmbh, Sandoz Pharmaceuticals Corp., Sandoz Pharm. Corp.. Active years: 1976-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William J Houlihan. Retrieved from https://idiyas.com/inventor/william-j-houlihan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 74

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 278(Granted Patents)

Forward Citations (Not Self Cited) = 252(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Mount Lakes, NJ (US) (1976)
  • Baden, OE (1976)
  • Lake Parsippany, NJ (US) (1978)
  • Mt. Lakes, NJ (US) (1979 - 1988)
  • Mountain Lake, NJ (US) (1990)
  • Mountain Lakes, NJ (US) (1976 - 1994)

Company Filing History:

goldMedal63 out of 1,603 
 
Sandoz Gmbh
 patents
silverMedal6 out of 18 
 
Sandoz Pharmaceuticals Corp.
 patents
bronzeMedal4 out of 36 
 
Sandoz Pharm. Corp.
 patents
4. 1 out of 834,570 
Other
 patents

Years Active: 1976-1994

Loading Chart...
Areas of Expertise:
Heterocyclic Phospholipids
Quinazolinones
Anti-Obesity Agents
Triglyceride Emulsions
Imidazo Compounds
Pyridazinones
Substituted Amines
Cyclopentane Derivatives
Dibenzimidazo Compounds
Stereoisomers
Pharmaceutical Vehicles
Biological Activity
74 patents (USPTO):Explore Patents
1. 5338730 - Use of the (R) isomer of (1994-08-16),
2. 5284836 - Heterocyclic phospholipids useful in treating multiple sclerosis (1994-02-08),
3. 5229377 - Process for the preparation of the (R) stereoisomer of the monobutyric (1993-07-20),
4. 5208352 - Process for preparing the R- and S-isomers of (1993-05-04),
5. 5182271 - Thioether, keto-ester and alkyl phospholipids useful in treating (1993-01-26),
6. 5141932 - 5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno pyridines (1992-08-25),
7. 5082846 - Use of the R-(+)-isomer of (1992-01-21),
8. 5064816 - Heterocyclic phospholipids useful in treating multiple sclerosis (1991-11-12),
9. 5010067 - Triglyceride-water emulsion pharmaceutical vehicles (1991-04-23),
10. 4992428 - 5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines (1991-02-12),
11. 4925851 - 2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines (1990-05-15),
12. 4914096 - 6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines (1990-04-03),
13. 4910206 - 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use (1990-03-20),
14. 4868319 - Process for the preparation of monoalkylcarbamate group-containing (1989-09-19),
15. 4845129 - Diaryl substituted cyclopentane and cyclopentene derivatives (1989-07-04),

Title: William J. Houlihan: Innovator in Pharmaceutical Chemistry

Introduction

William J. Houlihan is a distinguished inventor based in Mountain Lakes, NJ, with an impressive portfolio of 74 patents. His contributions to pharmaceutical chemistry have significantly advanced the field, particularly in the development of innovative compounds and processes.

Latest Patents

Houlihan's recent patents showcase his expertise in stereochemistry and drug development. One notable invention is a process for preparing the (R) stereoisomer of 2,2-bis(hydroxymethyl)-tetrahydrofuran monobutyrate. This process involves subjecting the dibutyric ester of this compound to enzymatic hydrolysis, resulting in a novel (R) stereoisomer. The invention not only introduces more stable forms of this stereoisomer but also explores its application in preparing pharmacologically active compounds.

Another significant patent involves heterocyclic phospholipids that are useful in treating multiple sclerosis. This invention discloses a variety of heterocyclic, thioether, keto-ester, and alkyl phospholipids, which have demonstrated potential in the therapeutic landscape for managing this condition.

Career Highlights

Throughout his career, William J. Houlihan has been associated with notable companies such as Sandoz GmbH and Sandoz Pharmaceuticals Corporation. His work within these organizations has contributed to various advancements in drug development and innovation. His extensive patent portfolio reflects his commitment to research and development in the pharmaceutical industry.

Collaborations

During his career, Houlihan has collaborated with esteemed professionals, including Jeffrey Nadelson and George A. Cooke. These partnerships have likely played a crucial role in his innovative processes and advancements, allowing for a blend of expertise and creativity in addressing complex pharmaceutical challenges.

Conclusion

William J. Houlihan's contributions to the field of pharmaceutical chemistry through his numerous patents illustrate the importance of innovation in developing effective therapies. His work in creating and refining compounds continues to impact the landscape of medicine, showcasing the vital role of inventors in advancing health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…